There is a consistent association between altered LV geometry, LV end-diastolic volume, and insulin resistance due to the effect of insulin on inducing hypertrophy and cellular growth, leading to interstitial fibrosis as a key factor in the pathogenesis of left ventricular hypertrophy (LVH) seen in advanced stages of DCM [29,30]. The gene discussed is INS; the disease is Insulin resistance.